Get started
BBB

ERIKA B-CURE

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

BCUR chart


Full chart

Key stats


Market capitalization
‪29.69 M‬ ILS
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.1 ILS
Net income (FY)
‪−19.22 M‬ ILS
Revenue (FY)
‪29.88 M‬ ILS
Shares float
‪21.64 M‬
Beta (1Y)
0.29

Employees


Employees (FY)
40
Change (1Y)
−18 −31.03%
Revenue / Employee (1Y)
‪205.75 K‬ ILS
Net income / Employee (1Y)
‪−132.34 K‬ ILS

About ERIKA B-CURE


Sector
Health Technology
Industry
Medical Specialties
CEO
Moti Navon
Website
bcurelaser.com
Headquarters
Haifa
Founded
2007
ISIN
IL0011789125
FIGI
BBG011YVTFL2
Erika B-Cure Laser Ltd. is an international company, which develops markets and distributes the B-Cure Laser products. It is designed to treat pain, orthopedic disorders, wounds and inflammations, for daily domestic use in the comfort of home; these are a series of revolutionary lightweight and portable devices. The company was founded on October 9, 2007 and is headquartered in Haifa, Israel.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BCUR is 28.8 ILA — it has increased by 1.05% in the past 24 hours. Watch ERIKA B-CURE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange ERIKA B-CURE stocks are traded under the ticker BCUR.
BCUR stock has risen by 12.06% compared to the previous week, the month change is a 19.01% rise, over the last year ERIKA B-CURE has showed a 55.68% increase.
BCUR reached its all-time high on Feb 15, 2022 with the price of 550.0 ILA, and its all-time low was 10.5 ILA and was reached on Nov 29, 2022. View more price dynamics on BCUR chart.
See other stocks reaching their highest and lowest prices.
BCUR stock is 4.64% volatile and has beta coefficient of 0.29. Track ERIKA B-CURE stock price on the chart and check out the list of the most volatile stocks — is ERIKA B-CURE there?
Today ERIKA B-CURE has the market capitalization of ‪29.69 M‬, it has increased by 6.23% over the last week.
Yes, you can track ERIKA B-CURE financials in yearly and quarterly reports right on TradingView.
BCUR net income for the last half-year is ‪93.00 K‬ ILS, while the previous report showed ‪−9.95 M‬ ILS of net income which accounts for 100.93% change. Track more ERIKA B-CURE financial stats to get the full picture.
No, BCUR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 40.00 employees. See our rating of the largest employees — is ERIKA B-CURE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ERIKA B-CURE EBITDA is ‪−7.96 M‬ ILS, and current EBITDA margin is −63.44%. See more stats in ERIKA B-CURE financial statements.
Like other stocks, BCUR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ERIKA B-CURE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ERIKA B-CURE technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ERIKA B-CURE stock shows the neutral signal. See more of ERIKA B-CURE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.